• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
44.84
86.16
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

NESO (a Lenskart subsidiary) acquires additional 2.77% stake in Le Petit Lunetier
Sep 24,2026

NESO Brand, Singapore (NESO), a wholly owned subsidiary of Lenskart Solutions, on 23 September 2026, made a further investment of EUR 0.248 million (equivalent to approximately Rs 2.71 crore) and acquired an additional 2.52% stake through primary subscription in Le Petit Lunetier Paris SAS, France (LPL), which is a French eyewear brand and among the existing portfolio of eyewear brands sold by the company. LPL is an existing associate entity of NESO and an indirect associate of the Company.

Earlier, NESO had acquired an additional 2.77% stake in LPL for EUR 0.25 million (equivalent to approximately Rs 2.77 crore) on 30 April 32026.

Accordingly, pursuant to the aforesaid acquisitions, the aggregate shareholding of NESO in LPL has increased from 29.05% to 34.34% of the fully diluted share capital of LPL, representing an aggregate increase of 5.30%.